Optiver Holding
COGT icon

Optiver Holding’s Cogent Biosciences COGT Stock Holding History

Optiver Holding’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.2K Buy
857
+335
+64% +$11.7K ﹤0.01% 1300
2026
Q1 		$20.1K Sell
522
-97
-16% -$3.58K ﹤0.01% 1099
2025
Q4 		$22K Sell
619
-129
-17% -$3.63K ﹤0.01% 1015
2025
Q3 		$10.7K Buy
+748
New +$8.86K ﹤0.01% 1253

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Optiver Holding's COGT Position: Q2 2026 in Review

Optiver Holding increased its Cogent Biosciences (COGT) stake by 64% in Q2 2026, buying an estimated $11.7K and bringing the position to 857 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Optiver Holding first reported a position in COGT in Q3 2025 and has held it in 4 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Optiver Holding held 857 shares of Cogent Biosciences worth $33.2K as of Q2 2026.
  • Optiver Holding bought 335 Cogent Biosciences shares in Q2 2026, an estimated $11.7K.
  • Cogent Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1300 holding.
  • Optiver Holding first reported a position in Cogent Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.